Top 20 of Fatty Liver

Article title # Publications/# Citations

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

2005: Nonalcoholic Steatohepatitis Clinical Research Network; CBehling; EMBrunt; MJContos; OWCummings; LDFerrell; DEKleiner; YCLiu; ... AJMcCullough; AJSanyal; MSTorbenson; AUnalp-Arida; MVan Natta; MYeh;

571

Nonalcoholic fatty liver disease.

2002: PAngulo;

452

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

2004: JDBrowning; JCCohen; RDobbins; SMGrundy; HHHobbs; JDHorton; PNuremberg; LSSzczepaniak;

406

Steatohepatitis: a tale of two "hits"?

1998: CPDay; OFJames;

382

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.

2006: KEgashira; KHiasa; HKanda; MKasuga; RKitazawa; SKitazawa; KKotani; SMaeda; ... HMiyachi; YTamori; STateya;

358

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

1999: BRBacon; EMBrunt; AMDi Bisceglie; CGJanney; BANeuschwander-Tetri;

275

The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

2005: LAAdams; PAngulo; AFeldstein; KDLindor; JFLymp; SOSanderson; JSt Sauver;

265

Molecular mediators of hepatic steatosis and liver injury.

2004: JDBrowning; JDHorton;

262

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

2005: MDBoldt; KLDonnelly; JJessurun; EJParks; SJSchwarzenberg; CISmith;

254

Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

2006: GCFarrell; CZLarter;

253

Thiazolidinediones.

2004: HYki-Järvinen;

238

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

1999: NBoparai; TGramlich; YCLiu; CAMatteoni; AJMcCullough; ZMYounossi;

235

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.

1999: BDesvergne; FJGonzalez; SKersten; JMPeters; JSeydoux; WWahli;

233

PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis.

2005: EDAbel; CBernal-Mizrachi; SBoudina; ZChen; MCourtois; BNFinck; JOHolloszy; DPKelly; ... JJLehman; TCLeone; DMMedeiros; JESaffitz; NSambandam; PJSchaeffer; RESchmidt; CFSemenkovich; ARWende; DFWozniak;

226

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

2003: EBugianesi; FCerrelli; GForlani; MLenzi; RManini; GMarchesini; NMelchionda; SNatale; ... MRizzetto; EVanni; NVillanova;

217

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

2004: DBefroy; SBilz; BDElder; ZXLiu; XQu; AJRomanelli; VTSamuel; GIShulman;

214

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.

2008: EBoerwinkle; JCCohen; DCox; HHHobbs; JKozlitina; LAPennacchio; APertsemlidis; SRomeo; CXing;

209

Human fatty liver disease: old questions and new insights.

2011: JCCohen; HHHobbs; JDHorton;

207

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

2001: GBianchi; MBrizi; EBugianesi; GForlani; MLenzi; GMarchesini; AJMcCullough; NMelchionda; SNatale; STomassetti;

206

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

2001: CCampbell-Sargent; JNClore; MJContos; VALuketic; FMirshahi; WBRizzo; AJSanyal; MLShiffman; RKSterling;

203